Detail

Study ID: AlexiWright SMART Study

Title:

Symptom Management and Reporting Toxicities

Description:
Title: The SMART Study Description: The SMART Study is a research study for women with gynecologic cancers. It is being conducted at Sanford Health, the University of New Mexico, and the Dana-Farber Cancer Institute. The SMART Study involves a smartphone app and a Fitbit watch. These are intended to help you manage chemotherapy symptoms and improve your quality of life.You will be enrolled in the study for three months (90 days). Every day, you will receive a short survey on your smartphone that asks about how you are feeling. If you are experiencing symptoms, the app will give you advice written by a gynecologic oncologist. If your symptoms seem worrisome, the app will tell you to call your doctor. You and your Sanford oncology team will receive summaries of your symptoms at your clinic visits. You will also be asked to wear a Fitbit watch, which counts how many steps you take. You will take a survey at the beginning and end of the study. You will receive $25 after each finished survey. The Fitbit is yours to keep at the end of the study. Key Inclusion Criteria: 1. English-speaking women over 20 years old with gynecologic cancers 2. Receiving chemotherapy for cancer that has recurred after one or more chemotherapy treatments 3. Own an Android or iOS smartphone that can run study app Key Exclusion Criteria: 1. Not currently counting steps with a wearable device (i.e. Fitbit, pedometer, step counter on your phone) 2. Not currently participating in a drug treatment trial
Location:
Sioux Falls Region
Principal Investigator:
Maria Bell, MD
Disease:
Other
Stage:
N/A
Status:
Active - Open to Accrual